Article: Dr. Peter B. Corr and Jean-Pierre Lehmann Appointed to Cibus Global Board of Directors.

SAN DIEGO -- Cibus Global, a leading plant trait development company, today announced the appointment of two board members to reflect its growing international reach. Peter B. Corr, Ph.D., co-founder and general partner of Celtic Therapeutics Management and former Corporate Senior Vice President of Science and Technology at Pfizer, brings to the Cibus Board of Directors three decades of experience in molecular biology, research and product development. Jean-Pierre Lehmann is an international businessman who has spent more than 20 years overseeing private company investments in diversified industries.

"Bringing these two distinguished directors to Cibus Global's ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!